Astrocytic activation and delayed infarct expansion after permanent focal ischemia in rats. Part II: Suppression of astrocytic activation by a novel agent (R)-(-)-2-propyloctanoic acid (ONO-2506) leads to mitigation of delayed infarct expansion and early improvement of neurologic deficits

Journal of Cerebral Blood Flow and Metabolism

Volumn 22, Issue 6, 2002, Pages 723-734

  Tateishi, Narito ^a   Mori, Takashi ^a   Kagamiishi, Yoshifumi ^a   Satoh, Souichi ^a   Katsube, Nobuo ^a   Morikawa, Eiharu ^a   Morimoto, Tadashi ^a   Matsui, Toru ^a   Asano, Takao ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Astrocyte; Cerebral ischemia; Cytokine; GFAP; ONO 2506; S 100

Indexed keywords

ARUNDIC ACID; GLIAL FIBRILLARY ACIDIC PROTEIN; INTERLEUKIN 1BETA; OCTANOIC ACID DERIVATIVE; PROTEIN S100B; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN INFARCTION; CELL ACTIVATION; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROPROTECTION; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN EXPRESSION; RAT; STROKE;

EID: 0036263210     PISSN: 0271678X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004647-200206000-00011     Document Type: Article

References (70)

1. 1A-receptor agonist, Bay x 3702
2. The ameliorative effect of ONO-2506 on the delayed and prolonged expansion of the infarct volume following pMCAO in rats
3. Induction of spreading depression in the ischemic hemisphere following experimental middle cerebral artery occlusion: Effect on infarct morphology
4. Enlargement of human cerebral ischemic lesion volume measured by diffusion-weighted magnetic resonance imaging
5. S-100β stimulates calcium fluxes in glial and neuronal cells
6. Disulfide-linked S100β dimers and signal transduction
7. Inflammatory mediator and stroke: New opportunities for novel therapeutics
8. Longitudinal magnetic resonance imaging study of perfusion and diffusion in stroke: Evolution of lesion volume and correlation with linical outcome
9. Rat middle cerebral artery occlusion: Evaluation the model and development of a neurologic examination
10. Transcriptional regulation of the human S100β gene
11. Cytokine-stimulated astrocytes damage human neurons via a nitric oxide mechanism
12. Astrocytic gap junctions remain open during ischemic conditions
13. Clinical trials with neuroprotective drugs in acute ischaemic stroke: Are we doing the right thing?
14. Thromboembolic events lead to cortical spreading depression and expression of c-fos, brain-derived neurotrophic factor, glial fibrillary acidic protein, and heat shock protein 70 mRNA in rats
15. Pathobiology of ischemic stroke: An integrated view
16. Very delayed infarction after mild focal cerebral ischemia: A role for apoptosis?
17. Molecular profile of reactive astrocytes-implications for their role in neurologic disease
18. Progression from ischemic injury to infarct following middle cerebral artery occlusion in the rat
19. Control of gap-junctional communication in astrocytic networks
20. Reactive glia as rivals in regulating neuronal survival
21. Microglia and macrophages are the major source of tumor necrosis factor in pMCAO in mice
22. Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease
23. Reactive astrocyte formation in vivo is regulated by noradrenergic axons
24. Dynamics of regional metabolism and gene expression after middle cerebral artery occlusion in mice
25. Regional heterogeneity in the response of astrocytes following traumatic brain injury in the adult rat
26. GFAP and S100β expression in the cortex and hippocampus in response to mild cortical contusion
27. Basic fibroblast growth factor-2 and interleukin-1 beta regulate S100 beta expression in cultured astrocytes
28. Viability thresholds and the penumbra of focal ischemia
29. S100β stimulates inducible nitric oxide synthase activity and mRNA levels in rat cortical astrocytes
30. S100β induces neuronal cell death through nitric oxide release from astrocytes
31. Amyloid-β peptide activates cultured astrocytes: Morphological alterations, cytokine induction and nitric oxide release
32. A receptor disappearance in cultured astrocytes and ischemic brain
33. Cortical spreading depression increases protein synthesis and upregulates basic fibroblast growth factor
34. Spreading depression increases immunohistochemical staining of glial fibrillary acidic protein
35. Glial fibrillary acidic protein transcription responses to transforming growth factor-β1 and interleukin-1β3 area mediated by a nuclear factor 1-like site in the near-upstream promoter
36. The changing landscape of ischaemic brain injury mechanisms
37. Gap junction-mediated propagation and amplification of cell injury
38. Expression of nitric oxide synthase (NOS)-2 following permanent focal ischemia and the role of nitric oxide in infarct generation in male, female and NONS-2 gene-deficient mice
39. Contribution of microglia/macrophages to expansion of infarction and response of oligodendrocytes after focal cerebral ischemia in rats
40. w-nitro-L-arginine attenuates early ischemic neuronal damage of prolonged focal cerebral ischemia and recirculation in rats
41. Astrocytic activation and delayed infarct expansion after permanent focal ischemia in rats. Part I: Enhanced astrocytic synthesis of S-100β in the periinfarct area precedes delayed infarct expansion
42. Correlation between periinfarct DC shifts and ischaemic neuronal damage in rat
43. Possible role of the superoxide anion in the development of neuronal tolerance following ischemic preconditioning in rats
44. Production of nitric oxide by glial cells: Regulation and potential roles in the CNS
45. Delayed treatment with aminoguanidine decreases focal cerebral ischemia damage and enhances neurologic recovery in rats
46. High susceptibility to cerebral ischemia in GFAP-null mice
47. Direct signaling from astrocytes to neurons in cultures of mammalian brain cells
48. Spreading depression is not associated with neuronal injury in the normal brain
49. Characterization of cortical depolarizations evoked in focal cerebral ischemia
50. Gap junctions are required for the propagation of spreading depression
51. Periinfarct and remote excitability changes after transient middle cerebral artery occlusion
52. Intracellular calcium oscillations in astrocytes: A highly plastic, bidirectional form of communication between neurons and astrocytes in situ
53. The two patterns of reactive astrocytosis in postischemic rat brain
54. Effective reduction of infarct volume by gap junction blockade in a rodent model of stroke
55. Global forebrain ischemia results in differential cellular expression of interleukin-1β and its receptor at mRNA and protein level
56. Reduction of infarct volume by halothane: Effect on cerebral blood flow or perifocal spreading depression-like depolarizations
57. Multiple molecular penumbras after focal cerebral ischemia
58. In vivo and in vitro evidence supporting a role for the inflammatory cytokine interleukin-1 as a driving force in Alzheimer pathogenesis
59. Time-dependent hypertrophic changes of the cultured astrocytes from rat cerebrum
60. ONO-2506, a novel astrocyte modulating agent, suppresses the increase of COX-2 and iNOS mRNA expression in cultured astrocytes and ischemic brain
61. ONO-2506 ameliorates neurodegeneration through inhibition of reduction of GLT-1 expression
62. Modulating effects of ONO-2506 on astrocytic activation in cultured astrocytes from rat cerebrum
63. Induction of nitric oxide synthase in glial cells
64. Exacerbation of ischemic brain damage by localized striatal injection of interleukin-1β in the rat
65. A receptors on primary cultured astrocytes from the rat brain
66. Regional accumulation of amyloid β/A4 protein precursor in the gerbil brain following transient cerebral ischemia
67. Glial cell line-derived neurotrophic factor protects against ischemia-induced injury in the cerebral cortex
68. Functional differentiation of multiple perilesional zones after focal cerebral ischemia
69. Glial fibrillary acidic protein is necessary for mature astrocytes to react to β-amyloid
70. Monitoring the temporal and spatial pattern of astrocytes in focal cerebral ischemia using in situ hybridization to GFAP mRNA: Comparison with sgp-2 and hsp70 mRNA and the effect of glutamate receptor antagonists